Document Detail


Massive fetomaternal hemorrhage: clearance of fetal red blood cells after intravenous anti-D prophylaxis monitored by flow cytometry.
MedLine Citation:
PMID:  18482192     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The clearance of D+ red blood cells (RBCs) from the circulation in D- individuals mediated by passively administered anti-D occurs by opsonization with the antibody and subsequent removal in the spleen. Few data exist on the kinetics of clearance of large volumes of D+ RBCs from the maternal circulation by anti-D in clinical cases of massive fetomaternal hemorrhage (FMH). CASE REPORT: A 33-year-old D- woman delivered a D+ female infant by emergency cesarean section for suspected fetal anemia. A massive FMH, initially estimated to be approximately 142 mL of RBCs, was found. In addition to the standard dose of intramuscular (IM) anti-D (300 microg) given immediately after delivery, 2700 microg of anti-D was administered intravenously (IV). The clearance of D+ fetal cells from the maternal circulation was monitored by flow cytometry in samples obtained on a daily basis using anti-D. The mother had no detectable anti-D 6 months after delivery. RESULTS: No clearance of fetal cells was apparent after the insufficient dose of IM anti-D. The IV administration of anti-D caused accelerated clearance of D+ fetal RBCs with a t1/2 of 24.5 hours. D+ reticulocytes comprised 4.2 percent of all D+ cells in the maternal circulation at delivery suggesting acute fetal blood loss. CONCLUSIONS: The approach used in this report allowed a detailed analysis of the kinetics related to the clearance of fetal D+ RBCs. Simultaneous measurements of fetal reticulocytes and fetal RBCs in maternal blood may establish the timing of an FMH.
Authors:
Rune Larsen; Adela Berkowicz; Thea Lousen; Morten Hedegaard; Frederik B Clausen; Grethe R Krog; Morten H Dziegiel
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-05-14
Journal Detail:
Title:  Transfusion     Volume:  48     ISSN:  0041-1132     ISO Abbreviation:  Transfusion     Publication Date:  2008 Aug 
Date Detail:
Created Date:  2008-08-20     Completed Date:  2008-09-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417360     Medline TA:  Transfusion     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1707-12     Citation Subset:  IM    
Affiliation:
Department of Clinical Immunology, University Hospital of Copenhagen (Rigshospitalet), Copenhagen, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cesarean Section
Erythroblastosis, Fetal / blood,  immunology
Female
Fetal Blood / cytology*
Fetomaternal Transfusion / blood*,  immunology*
Flow Cytometry / methods*
Humans
Infant, Newborn
Injections, Intravenous
Isoantibodies / administration & dosage*,  blood,  immunology
Pregnancy
Pregnancy Outcome
Reticulocytes / cytology
Spleen / cytology
Chemical
Reg. No./Substance:
0/Isoantibodies; 0/RHO(D) antibody

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The suitability of hemolyzed specimens for compatibility testing using automated technology.
Next Document:  Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use o...